A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF SWITCHING FROM INNOVATOR INFLIXIMAB TO BIOSIMILAR INFLIXIMAB COMPARED WITH CONTINUED TREATMENT WITH INNOVATOR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, PSORIATIC ARTHRITIS, ULCERATIVE COLITIS, CROHN'S DISEASE AND CHRONIC PLAQUE PSORIASIS THE NOR-SWITCH STUDY

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02148640

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:48.251609+00:00

Published At

2017-09-25T00:00:00+00:00

Record Updated At

2017-09-25

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Rheumatoid Arthritis", "Spondyloarthritis", "Psoriatic Arthritis", "Ulcerative Colitis", "Crohn\u0027s Disease", "Psoriasis Chronic"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2017-09-25"

protocolSection.identificationModule.nctId

"NCT02148640"

protocolSection.identificationModule.officialTitle

"A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF SWITCHING FROM INNOVATOR INFLIXIMAB TO BIOSIMILAR INFLIXIMAB COMPARED WITH CONTINUED TREATMENT WITH INNOVATOR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, PSORIATIC ARTHRITIS, ULCERATIVE COLITIS, CROHN\u0027S DISEASE AND CHRONIC PLAQUE PSORIASIS THE NOR-SWITCH STUDY"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE4"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Rheumatoid Arthritis (protocolSection.conditionsModule.conditions)
• Spondyloarthritis (protocolSection.conditionsModule.conditions)
• Psoriatic Arthritis (protocolSection.conditionsModule.conditions)
• Ulcerative Colitis (protocolSection.conditionsModule.conditions)
• Crohn's Disease (protocolSection.conditionsModule.conditions)
• Psoriasis Chronic (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.